1. Determination of Immunoreactive Fraction of Radiolabeled Monoclonal Antibodies: What Is an Appropriate Method?
Cancer Biotherapy & Radiopharmaceuticals Volume: 19 Issue 6: January 21, 2005
Код: Выделить всё
http://dx.doi.org/10.1089/cbr.2004.19.706Gerhard Glatting, Sven N. Reske
Cancer Biotherapy & Radiopharmaceuticals. 2006: 15-21.
Код: Выделить всё
http://dx.doi.org/10.1089/cbr.2006.21.15M. Jules Mattes
Cancer Biotherapy & Radiopharmaceuticals. December 2004: 667-668.
Код: Выделить всё
http://dx.doi.org/10.1089/cbr.2004.19.6674. Pharmacokinetics, Biodistribution, and Radioimmunotherapy with Monoclonal Antibody 776.1 in a Murine Model of Human Ovarian Cancer
Marc A. Berger, Gregg R. Masters, Judith Singleton, Michael S. Scully, Lisa G. Grimm, Daniel A. Soltis, Earl F. Albone,
Cancer Biotherapy & Radiopharmaceuticals. December 2005: 589-602.
Код: Выделить всё
http://dx.doi.org/10.1089/cbr.2005.20.589Raymond Reilly
Cancer Biotherapy & Radiopharmaceuticals. December 2004: 669-672.
Код: Выделить всё
http://dx.doi.org/10.1089/cbr.2004.19.669